Current Rheumatology Reports

, Volume 5, Issue 2, pp 154–159 | Cite as

Microchimerism and scleroderma: An update

  • Carol M. Artlett
Article

Abstract

Microchimerism has been defined by the presence of a low number of circulating cells transferred from one individual to another. This transfer takes place naturally during pregnancy, between mother and fetus, or between fetuses in multigestational pregnancies. Furthermore, the establishment of microchimerism can also occur during blood transfusion, as well as during bone marrow and solid-organ transplants. Recently, microchimeric cells have been implicated in the pathogenesis of autoimmune diseases, particularly systemic sclerosis. Studies have demonstrated an increased presence of microchimeric cells in peripheral blood and tissues from patients with systemic sclerosis, and, more recently, microchimeric cells were demonstrated to be specifically activated and capable of recognizing patient human leukocyte antigens.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Artlett CM, Smith JB, Jimenez SA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Eng J Med 1998, 338:1186–1191. This paper is a seminal publication that demonstrates, for the first time, the presence of fetal microchimeric cells in the active lesions of patients with SSc, and also that microchimeric cells in the peripheral blood are CD3+ T cells.CrossRefGoogle Scholar
  2. 2.
    Artlett CM, Cox LA, Ramos RC, et al.: Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis. Clin Immunol 2002, 103:303–308. This paper identifies the presence of fetal microchimeric cells in the CD4+ T cell population in peripheral blood. CD4+ T cells are important effector molecules in mediating GVHD. This article adds support to the hypothesis that SSc may be a GVHD mediated disease.CrossRefPubMedGoogle Scholar
  3. 3.
    Artlett CM, Welsh KI, Black CM, Jimenez SA: Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997, 47:17–22. This article is the first report of HLA class II compatibility between SSc patients and offspring and their mothersCrossRefPubMedGoogle Scholar
  4. 4.
    Nelson JL, Furst DE, Maloney S, et al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559–562. This publication confirms the Artlett et al. [3] study by demonstrating HLA compatibility in SSc families; it also demonstrates microchimeric cells in the peripheral blood of women with SSc.CrossRefPubMedGoogle Scholar
  5. 5.
    Artlett CM: Microchimerism in health and disease. Curr Molec Med 2002, 2:525–535.CrossRefGoogle Scholar
  6. 6.
    Artlett CM, Smith JB, Jimenez SA: New perspectives on the etiology of systemic sclerosis. Molec Med Today 1999, 5:74–78.CrossRefGoogle Scholar
  7. 7.
    McCormick LL, Zhang Y, Tootell E, Gilliam AC: Anti-TGF-b treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999, 163:5693–5699.PubMedGoogle Scholar
  8. 8.
    Zhang Y, McCormick LL, Desai SR, et al.: Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088–3098. This article investigates and demonstrates the importance of the murine sclerodermatous GVHD as a model for SSc.PubMedGoogle Scholar
  9. 9.
    Evans PC, Lambert N, Maloney S, et al.: Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033–2037.PubMedGoogle Scholar
  10. 10.
    Lambert NC, Evans PC, Hashizumi TL, et al.: Persistent fetal microchimerism in T lymphocytes is associated with HLADQA1* 0501: implications in autoimmunity. J Immunol 2000, 164:5545–5548.PubMedGoogle Scholar
  11. 11.
    Artlett CM, Sawaya HHB, Russo-Stieglitz KE, et al.: Persistent microchimerism is not associated with HLA-DQA1 in systemic sclerosis or juvenile myositis [manuscript submitted for publication]. Journal 2003, In press.Google Scholar
  12. 12.
    Moudgil KD, Sercarz EE: The self-directed T cell repertoire: its creation and activation. Rev Immunogenet 2000, 2:26–37.PubMedGoogle Scholar
  13. 13.
    Sakkas LI, Xu B, Artlett CM, et al.: Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002, 168:3649–3659.PubMedGoogle Scholar
  14. 14.
    Gaschet J, Trevino MA, Cherel M, et al.: HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during graft-versus-host disease. Blood 1996, 87:2345–2353.PubMedGoogle Scholar
  15. 15.
    Schultz KR, Paquet J, Bader S, HayGlass KT: Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease. Bone Marrow Transplant 1995, 16:289–295.PubMedGoogle Scholar
  16. 16.
    Datta AR, Barrett AJ, Jiang YZ, et al.: Distinct T cell populations distinguish chronic myeloid leukemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions. Bone Marrow Transplant 1994, 14:517–524.PubMedGoogle Scholar
  17. 17.
    Murata H, Nakauchi H, Sumida T: Microchimerism in Japanese women patients with systemic sclerosis. Lancet 1999, 354:220–220.CrossRefPubMedGoogle Scholar
  18. 18.
    Miyashita Y, Ono M, Ueki H, Kurasawa K: Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 2000, 59:655–656.CrossRefPubMedGoogle Scholar
  19. 19.
    Ichikawa N, Kotake S, Hakoda M, Kamatani N: Microchimerism in Japanese patients with systemic sclerosis. Arthritis Rheum 2001, 44:1226–1228.CrossRefPubMedGoogle Scholar
  20. 20.
    Lo YMD: Non-invasive prenatal diagnosis using fetal cells in maternal blood. J Clin Pathol 1994, 47:1060–1065.CrossRefPubMedGoogle Scholar
  21. 21.
    Lo YMD, Lau TK, Chan LYS, et al.: Quantitative analysis of bi-directional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000, 46:1301–1309.PubMedGoogle Scholar
  22. 22.
    Thomson AW, Lu L, Wan Y, et al.: Identification of donorderived dendritic cells progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 1995, 60:1555–1559.PubMedCrossRefGoogle Scholar
  23. 23.
    Martin WL, Durrant LG, Liu DTY: Non-invasive fetal cell isolation from maternal blood. Br J Obstet Gynecol 1998, 105:576–583.Google Scholar
  24. 24.
    Cox LA, Ramos RC, Dennis TN, et al.: Detection of microchimeric cells in the peripheral blood of non-pregnant women is enhanced by magnetic cell sorting prior to PCR. Arthritis Rheum 2003, In press.Google Scholar
  25. 25.
    Ohtsuka T, Miyamoto Y, Yamakage A, Yamazaki S: Quantitative analysis of microchimerism in systemic sclerosis tissue. Arch Dermatol Res 2001, 293:387–391. This article reports that SSc lesions have increased numbers of fetal microchimeric cells compared with other autoimmune diseases and control individuals.CrossRefPubMedGoogle Scholar
  26. 26.
    Scaletti C, Vultaggio A, Bonifacio S, et al.: TH2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002, 46:445–450. This paper was the first to demonstrate that male fetal cells actively recognize the HLA alleles from patients with SSc, use mixed lymphocyte reactiona, and that these cells produce an abundance of interleukin-4.CrossRefPubMedGoogle Scholar
  27. 27.
    Artlett CM, Sawaya HHB, Johnson-Hopson CN, et al.: Microchimeric cells identified by immunophenotyping and fluorescence in situ hybridization in active lesions from patients with systemic sclerosis are activated T cells. Arthritis Rheum 2003, In press. This abstract investigates the phenotypes of the microchimeric cells in the active lesions of patients with SSc and that these cells are activated T cells.Google Scholar
  28. 28.
    Tanei R, Yamamoto T, Yokono H, Motoori T: Scaling lichenoid eruptions and Sjogren-like syndrome: manifestations of nonfatal postoperative transfusion-associated graft-versushost disease. J Dermatol 1997, 24:514–521.PubMedGoogle Scholar
  29. 29.
    Srivasta B, Srivasta S, Johnson KL, et al.: Microchimerism of presumed fetal origin in thyroid specimens from women: a case controlled study. Lancet 2001, 358:2034–2038.CrossRefGoogle Scholar
  30. 30.
    Ferrari G, Cusella-De Angelis G, Coletta M, et al.: Muscle regenaretion by bone-marrow derived myogenic progenitors. Science 1998, 279:1528–1530.CrossRefPubMedGoogle Scholar
  31. 31.
    Morrison SJ: Stem cell potential: can anything make anything? Curr Biology 2001, 11:R7-R9.CrossRefGoogle Scholar
  32. 32.
    Bjornson CRR, Rietze RL, Reynolds BA, et al.: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999, 283:534–537.CrossRefPubMedGoogle Scholar
  33. 33.
    Anderson DJ, Gage FH, Weissman IL: Can stem cells cross lineage boundaries? Nat Med 2001, 7:393–395. This paper reviews the current concepts of cells crossing lineage boundaries by transdifferention via genomic reprogramming.CrossRefPubMedGoogle Scholar
  34. 34.
    Klintschar M, Schwaiger P, Mannweiler S, et al.: Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 2001, 86:2494–2498.CrossRefPubMedGoogle Scholar
  35. 35.
    Aractingi S, Sibilia J, Meignin V, et al.: Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjogren’s syndrome. Arthritis Rheum 2002, 46:1039–1043. Identification of microchimeric cells in the salivary glands of patients with SSc, but not in patients with Sjögren’s syndrome.CrossRefPubMedGoogle Scholar
  36. 36.
    Endo Y, Negishi I, Ishikawa O: Possible contribution of microchimerism to the pathogenesis of Sjögren’s syndrome. Rheumatology 2002, 41:490–495.CrossRefPubMedGoogle Scholar
  37. 37.
    Pisa FE, Bovenzi M, Romeo L, et al.: Reproductive factors and the risk of scleroderma. Arthritis Rheum 2002, 46:451–456.CrossRefPubMedGoogle Scholar
  38. 38.
    Artlett CM, Rasheed M, Russo-Stieglitz KE, et al.: Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis 2002, 61:346–350.CrossRefPubMedGoogle Scholar
  39. 39.
    Launay D, Hebbar M, Hatron PY, et al.: Relationship between parity and clinical and biological features in patients with systemic sclerosis. J Rheumatol 2001, 28:509–513.PubMedGoogle Scholar

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • Carol M. Artlett
    • 1
  1. 1.Division of Rheumatology, Department of MedicineThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations